Alternatives to lithium for preventive treatment of bipolar disorder
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The authors review the research literature on drug treatment for the prevention of recurrences in bipolar disorder, emphasizing the available alternatives to lithium therapy. They discuss the need for alternative treatments and the current status of promising agents. Carbamazepine receives special attention because of its status as the most promising backup treatment for lithium. The authors conclude that despite the extensive literature on carbamazepine, there is strong need for carefully designed, prospective, double-blind studies to establish the efficacy of carbamazepine alone and in combination with lithium as a prophylactic treatment for bipolar disorder. Difficulties in developing and evaluating preventive maintenance are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Prien, R. F. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220086014 · Cited by 565
Self-citationPrien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200030104017 · Cited by 448
Self-citationRapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants
Wehr, T. A. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050065007 · Cited by 408
Flupenthixol decanoate in recurrent manic‐depressive illness: A COMPARISON WITH LITHIUM
Ahlfors, U. G., Baastrup, P. C., Dencker, S. J., Elgen, K., Lingjærde, O., Pedersen, V., Schou, M., & Aaskoven, O. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00778.x · Cited by 155
Koch-Weser, J., & Browne, T. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810122991505 · Cited by 106
WEHR, T. A., & GOODWIN, F. K. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.7.906-a · Cited by 60
Cited by
Course and outcome in bipolar affective disorder: a longitudinal follow- up study
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.379 · Cited by 369
Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.4.431 · Cited by 266
Differential Response to Lithium and Carbamazepine in the Prophylaxis of Bipolar Disorder
Greil, W., Kleindienst Nikolaus, D.-S., Erazo Natalia, D.-P., & Muller-Oerlinghausen, B. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00007 · Cited by 206
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.413 · Cited by 112
Grof, P., Alda, M., Grof, E., Fox, D., & Cameron, P. (1993) · British Journal of Psychiatry · doi:10.1192/s000712500029243x · Cited by 102
Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01356.x · Cited by 90
“Many placebo-controlled trials [6] demonstrate that it reduces both frequency and severity of manic and depressive episodes (lesser recurrence in 50% and no relapse at all in 20% [134]).”
BackgroundBauer, M. S., Williford, W. O., Dawson, E. E., Akiskal, H. S., Altshuler, L., Fye, C., Gelenberg, A., Glick, H., Kinosian, B., & Sajatovic, M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00440-2 · Cited by 80
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1989-07-01
- Volume
- 146
- Issue
- 7
- Pages
- 840-848
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1717510248
- Cited by
- 107
- References
- 7
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.